Shriram Revankar, who serves as a senior vice president at Dolby Laboratories, Inc. (NASDAQ: DLB), sold 3,000 shares of Class A common stock on February 17, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at a price of $66.14 per share, producing total proceeds of $198,420. Following the disposition, Revankar’s reported ownership stood at 83,218 shares in total. That figure includes 59,172 shares that are attributable to restricted stock units; those units remain subject to forfeiture until they vest.
The filing specifies that the shares were directly owned by Revankar. The document also indicates that the Form 4 was signed by Daniel Rodriguez, acting as Attorney-in-Fact for Shriram Revankar.
Dolby Laboratories disclosed quarterly financial results around the same period. For the first quarter of 2026 the company recorded earnings per share of $1.06, compared with a consensus forecast of $0.88, representing a 20.45% positive surprise versus expectations. Revenue for the quarter came in at $347 million, above the $332.07 million analysts had been expecting.
Those outsized results were followed by an upward move in the company’s share price, according to the filing. The company’s reported earnings and revenue both exceeded market forecasts, a performance noted in the filing as a notable achievement for Dolby Laboratories in the current fiscal year.
The Form 4 provides a snapshot of an insider sale that coincides with a quarter in which the company reported stronger-than-expected financial metrics. The filing also clarifies the composition of the executive’s remaining holdings, including the portion that remains contingent on future vesting events.
All information on the transaction amount, share count, pricing, post-sale holdings and the role of the Attorney-in-Fact is drawn from the SEC Form 4 filing and Dolby’s reported quarterly results as stated in the company’s filings.